Alyeska Investment Group, L.P. Cooper Companies, Inc. Transaction History

Alyeska Investment Group, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$306.88 - $380.0 $14.2 Million - $17.6 Million	46,186 Added 31.18%	194,298 $73.5 Million
Q2 2023 Aug 14, 2023	SELL	$346.15 - $392.09 $12.1 Million - $13.7 Million	-35,056 Reduced 19.14%	148,112 $56.8 Million
Q1 2023 May 15, 2023	SELL	$323.56 - $373.36 $20.5 Million - $23.7 Million	-63,424 Reduced 25.72%	183,168 $68.4 Million
Q4 2022 Feb 14, 2023	BUY	$248.67 - $334.17 $61.3 Million - $82.4 Million	246,592 New	246,592 $81.5 Million
Q3 2020 Nov 16, 2020	SELL	$280.08 - $347.78 $12.7 Million - $15.8 Million	-45,328 Reduced 46.91%	51,309 $17.3 Million
Q3 2018 Nov 14, 2018	SELL	$236.3 - $277.15 $7.85 Million - $9.2 Million	-33,200 Reduced 25.57%	96,637 $26.8 Million
Q2 2018 Aug 14, 2018	BUY	$217.98 - $237.23 $28.3 Million - $30.8 Million	129,837 New	129,837 $30.6 Million

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.